LU86971A1 - Compositions pharmaceutiques pour l'administration par voie nasale - Google Patents

Compositions pharmaceutiques pour l'administration par voie nasale Download PDF

Info

Publication number
LU86971A1
LU86971A1 LU86971A LU86971A LU86971A1 LU 86971 A1 LU86971 A1 LU 86971A1 LU 86971 A LU86971 A LU 86971A LU 86971 A LU86971 A LU 86971A LU 86971 A1 LU86971 A1 LU 86971A1
Authority
LU
Luxembourg
Prior art keywords
sms
composition according
administration
nasal
compositions
Prior art date
Application number
LU86971A
Other languages
English (en)
French (fr)
Original Assignee
Sandoz Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB868620035A external-priority patent/GB8620035D0/en
Priority claimed from GB868626821A external-priority patent/GB8626821D0/en
Application filed by Sandoz Sa filed Critical Sandoz Sa
Publication of LU86971A1 publication Critical patent/LU86971A1/fr

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0043—Nose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22—Hormones
    • A61K38/31—Somatostatins

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Endocrinology (AREA)
  • Zoology (AREA)
  • Otolaryngology (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
LU86971A 1986-08-18 1987-08-14 Compositions pharmaceutiques pour l'administration par voie nasale LU86971A1 (fr)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
GB8620035 1986-08-18
GB868620035A GB8620035D0 (en) 1986-08-18 1986-08-18 Organic compounds
GB868626821A GB8626821D0 (en) 1986-11-10 1986-11-10 Organic compounds
GB8626821 1986-11-10

Publications (1)

Publication Number Publication Date
LU86971A1 true LU86971A1 (fr) 1988-03-02

Family

ID=26291187

Family Applications (1)

Application Number Title Priority Date Filing Date
LU86971A LU86971A1 (fr) 1986-08-18 1987-08-14 Compositions pharmaceutiques pour l'administration par voie nasale

Country Status (24)

Country Link
KR (1) KR880002537A (pt)
AT (1) AT396331B (pt)
AU (2) AU612589B2 (pt)
BE (1) BE1001748A4 (pt)
CA (1) CA1322331C (pt)
CH (1) CH672252A5 (pt)
CS (1) CS411491A3 (pt)
DE (1) DE3726517A1 (pt)
DK (1) DK428287A (pt)
ES (1) ES2004807A6 (pt)
FI (1) FI93307C (pt)
FR (1) FR2602680B1 (pt)
GR (1) GR871289B (pt)
HK (1) HK80493A (pt)
HU (1) HU200940B (pt)
IE (1) IE60761B1 (pt)
IL (1) IL83572A (pt)
IT (1) IT1222510B (pt)
LU (1) LU86971A1 (pt)
NL (1) NL8701874A (pt)
NO (1) NO175519C (pt)
NZ (1) NZ221473A (pt)
PT (1) PT85545B (pt)
SE (1) SE8703183L (pt)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1485117A4 (en) 2002-01-22 2006-03-22 Univ New York METHOD FOR THERAPEUTIC TREATMENT OF BENIGN PROSTATE HYPERTROPHY (BPH)

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS6034925B2 (ja) * 1979-07-31 1985-08-12 帝人株式会社 持続性鼻腔用製剤およびその製造法
DE3062075D1 (en) * 1979-11-27 1983-03-24 Sandoz Ag Polypeptides, processes for their production, pharmaceutical compositions comprising said polypeptides and their use
US4451394A (en) * 1982-10-25 1984-05-29 American Home Products Corporation Dodecapeptides preventing glucose and triglyceride assimilation
JPS59163313A (ja) * 1983-03-09 1984-09-14 Teijin Ltd 経鼻投与用ペプチドホルモン類組成物
US4505897A (en) * 1983-04-18 1985-03-19 The Administrators Of The Tulane Educational Fund Cyclic pentapeptides displaying somatostatin antagonism and method of treatment of mammals therewith
GB8514090D0 (en) * 1985-06-04 1985-07-10 Sandoz Ltd Organic compounds
US4612302A (en) * 1983-11-14 1986-09-16 Brigham And Women's Hospital Clinical use of somatostatin analogues
JPS60224616A (ja) * 1984-04-24 1985-11-09 Teijin Ltd 経鼻投与用組成物
US4725577A (en) * 1985-04-25 1988-02-16 Administrators Of The Tulane Educational Fund Biologically active lysine containing octapeptides
JPH085913B2 (ja) * 1985-09-12 1996-01-24 ザ・アドミニストレ−タ−ズ・オブ・ザ・ツ−レイン・エデユケイシヨナル・フアンド 治療用ソマトスタチン同族体

Also Published As

Publication number Publication date
KR880002537A (ko) 1988-05-09
NZ221473A (en) 1990-08-28
IT8721670A0 (it) 1987-08-18
NO175519C (no) 1994-10-26
FR2602680B1 (fr) 1993-04-16
IL83572A (en) 1992-09-06
SE8703183D0 (sv) 1987-08-17
ES2004807A6 (es) 1989-02-01
AT396331B (de) 1993-08-25
NO175519B (no) 1994-07-18
ATA206087A (de) 1992-12-15
PT85545A (en) 1987-09-01
SE8703183L (sv) 1988-02-19
CA1322331C (en) 1993-09-21
IE872187L (en) 1988-02-18
NO873452D0 (no) 1987-08-17
DK428287A (da) 1988-02-19
IE60761B1 (en) 1994-08-10
FI93307C (fi) 1995-03-27
IT1222510B (it) 1990-09-05
NO873452L (no) 1988-02-19
FI93307B (fi) 1994-12-15
FI873548A0 (fi) 1987-08-17
AU637530B2 (en) 1993-05-27
AU8568991A (en) 1991-12-05
AU612589B2 (en) 1991-07-18
DK428287D0 (da) 1987-08-17
AU7712087A (en) 1988-02-25
FI873548A (fi) 1988-02-19
BE1001748A4 (fr) 1990-02-27
DE3726517A1 (de) 1988-03-03
PT85545B (pt) 1990-05-31
NL8701874A (nl) 1988-03-16
GR871289B (en) 1987-12-18
CH672252A5 (pt) 1989-11-15
HU200940B (en) 1990-09-28
HUT46235A (en) 1988-10-28
CS411491A3 (en) 1992-06-17
HK80493A (en) 1993-08-13
FR2602680A1 (fr) 1988-02-19
IL83572A0 (en) 1988-01-31

Similar Documents

Publication Publication Date Title
AU2021203035B2 (en) Nasal Powder Formulation for Treatment of Hypoglycemia
JP2548056B2 (ja) Ｉ型糖尿病に係る自己免疫疾患の抑制および予防用製剤
JP4499282B2 (ja) 混合ミセル状薬剤の移送システム及び調製方法
FR2582511A1 (fr) Systeme d'application endonasal
JPH03502920A (ja) 経粘膜デリバリー製剤およびその製法
EP2670368A1 (en) New oral dissolving films for insulin administration, for treating diabetes
GB2193891A (en) Nasal pharmaceutical compositions containing octreotide
BE1001748A4 (fr) Compositions pharmaceutiques pour l'administration par voie nasale.
US20030079747A1 (en) Method of decreasing fasting sugars and weight gains in diabetic patients
JP2022514340A (ja) 過剰摂取および報酬に基づく障害を処置するための、組成物、装置、および方法
JPS6357528A (ja) 新規製剤
JP2004533438A (ja) エーロゾル化したインスリンによる２型糖尿病の予防法
Dugger III et al. Immediate-Immediate Release (I2R) Lingual or Buccal Spray Formulations for Transmucosal Delivery of Drug Substances
AU2006203457A1 (en) Method of decreasing fasting sugars and weight gains in diabetic patients